These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 19926811)

  • 1. A mathematical model of homeostatic regulation of sleep-wake cycles by hypocretin/orexin.
    Postnova S; Voigt K; Braun HA
    J Biol Rhythms; 2009 Dec; 24(6):523-35. PubMed ID: 19926811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of orexin/hypocretin in regulation of sleep/wakefulness and energy homeostasis.
    Sakurai T
    Sleep Med Rev; 2005 Aug; 9(4):231-41. PubMed ID: 15961331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic interactions between orexin and dynorphin may delay onset of functional orexin effects: a modeling study.
    Williams KS; Behn CG
    J Biol Rhythms; 2011 Apr; 26(2):171-81. PubMed ID: 21454297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuronal activity of orexin and non-orexin waking-active neurons during wake-sleep states in the mouse.
    Takahashi K; Lin JS; Sakai K
    Neuroscience; 2008 May; 153(3):860-70. PubMed ID: 18424001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of the hypocretin/orexins in the regulation of sleep and wakefulness.
    Terao A; Haruyama T; Kimura K
    Jpn J Vet Res; 2008 Jan; 55(2-3):75-83. PubMed ID: 18318109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orexin neuronal circuitry: role in the regulation of sleep and wakefulness.
    Ohno K; Sakurai T
    Front Neuroendocrinol; 2008 Jan; 29(1):70-87. PubMed ID: 17910982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The orexin system: roles in sleep/wake regulation.
    Sakurai T; Mieda M; Tsujino N
    Ann N Y Acad Sci; 2010 Jul; 1200():149-61. PubMed ID: 20633143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of sleep-wake patterns in a novel transgenic mouse line overexpressing human prepro-orexin/hypocretin.
    Mäkelä KA; Wigren HK; Zant JC; Sakurai T; Alhonen L; Kostin A; Porkka-Heiskanen T; Herzig KH
    Acta Physiol (Oxf); 2010 Mar; 198(3):237-49. PubMed ID: 20003098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-sleep effects of hypocretin/orexin.
    Samson WK; Taylor MM; Ferguson AV
    Sleep Med Rev; 2005 Aug; 9(4):243-52. PubMed ID: 16036174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dual role of the orexin/hypocretin system in modulating wakefulness and respiratory drive.
    Gestreau C; Bévengut M; Dutschmann M
    Curr Opin Pulm Med; 2008 Nov; 14(6):512-8. PubMed ID: 18812827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overview of orexin/hypocretin system.
    Mieda M; Sakurai T
    Prog Brain Res; 2012; 198():5-14. PubMed ID: 22813966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orexins: from neuropeptides to energy homeostasis and sleep/wake regulation.
    Beuckmann CT; Yanagisawa M
    J Mol Med (Berl); 2002 Jun; 80(6):329-42. PubMed ID: 12072908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microdialysis perfusion of orexin-A in the basal forebrain increases wakefulness in freely behaving rats.
    Thakkar MM; Ramesh V; Strecker RE; McCarley RW
    Arch Ital Biol; 2001 Apr; 139(3):313-28. PubMed ID: 11330208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity-dependent release of adenosine inhibits the glutamatergic synaptic transmission and plasticity in the hypothalamic hypocretin/orexin neurons.
    Xia J; Chen F; Ye J; Yan J; Wang H; Duan S; Hu Z
    Neuroscience; 2009 Sep; 162(4):980-8. PubMed ID: 19465088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of orexins/hypocretins on neuronal activity in the paraventricular nucleus of the thalamus in rats in vitro.
    Ishibashi M; Takano S; Yanagida H; Takatsuna M; Nakajima K; Oomura Y; Wayner MJ; Sasaki K
    Peptides; 2005 Mar; 26(3):471-81. PubMed ID: 15652654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A quartet neural system model orchestrating sleep and wakefulness mechanisms.
    Tamakawa Y; Karashima A; Koyama Y; Katayama N; Nakao M
    J Neurophysiol; 2006 Apr; 95(4):2055-69. PubMed ID: 16282204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypocretins (orexins): clinical impact of the discovery of a neurotransmitter.
    Baumann CR; Bassetti CL
    Sleep Med Rev; 2005 Aug; 9(4):253-68. PubMed ID: 15979356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Input of orexin/hypocretin neurons revealed by a genetically encoded tracer in mice.
    Sakurai T; Nagata R; Yamanaka A; Kawamura H; Tsujino N; Muraki Y; Kageyama H; Kunita S; Takahashi S; Goto K; Koyama Y; Shioda S; Yanagisawa M
    Neuron; 2005 Apr; 46(2):297-308. PubMed ID: 15848807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orexin (hypocretin)/dynorphin neurons control GABAergic inputs to tuberomammillary neurons.
    Eriksson KS; Sergeeva OA; Selbach O; Haas HL
    Eur J Neurosci; 2004 Mar; 19(5):1278-84. PubMed ID: 15016085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orexins/hypocretins and aminergic systems.
    Eriksson KS; Sergeeva OA; Haas HL; Selbach O
    Acta Physiol (Oxf); 2010 Mar; 198(3):263-75. PubMed ID: 19566795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.